肝细胞特异性敲除IL1-RI通过阻断IL-1驱动的自身炎症减轻肝损伤
该研究利用肝细胞条件性敲除IL-1R1的小鼠模型(Il1r1Hep-/-),发现D-半乳糖胺联合脂多糖诱导的急性肝衰竭在敲除鼠中显著减轻、死亡率降低,机制涉及JNK/c-Jun、NF-κB p65、ERK、caspase 3及NLRP3炎症小体通路,且IL-1ra(阿那白滞素)抑制IL-1R1可减轻肝损伤严重程度。
要点
- 肝细胞IL-1R1缺失减轻D-GalN/LPS诱导的急性肝衰竭并降低死亡率。
- IL-1R1缺失减少局部及全身炎症因子、趋化因子水平和中性粒细胞浸润。
- IL-1ra(阿那白滞素)抑制IL-1R1减轻肝损伤严重程度,IL-1α给药加重损伤。
核心结论
- 肝细胞IL-1R1在急性肝衰竭起病阶段IL-1驱动的细胞死亡与炎症自身放大中起关键作用。
研究设计与样本
- 研究采用肝细胞中所有具备信号传导能力的IL-1R亚型均被敲除的新型转基因小鼠模型(Il1r1Hep-/-)。
- 以D-半乳糖胺(D-GalN)联合脂多糖(LPS)诱导急性肝衰竭。
主要发现
- Il1r1Hep-/-小鼠中D-GalN/LPS诱导的急性肝衰竭显著减轻并导致死亡率降低。
- 条件性敲除Il1r1降低损伤性JNK/c-Jun信号激活、活化NF-κB p65、抑制ERK并阻止caspase 3介导的凋亡。
- Il1r1Hep-/-小鼠局部及全身炎症细胞因子和趋化因子水平降低,尤其TNF-α、IL-1α/β、IL-6、CCL2、CXCL-1和CXCL-2,且损伤时肝组织中性粒细胞募集减少。
- 缺乏肝细胞IL-1R1时NLRP3炎症小体表达和caspase 1活化受抑制。
- 使用IL-1ra(阿那白滞素)抑制IL-1R1减轻肝损伤严重程度,而给予IL-1α加重损伤;这些效应在离体和较晚时间点消失,支持IL-1R1在急性肝损伤中炎症信号放大中的作用。
临床怎么用
- 作者指出,本研究结果提示通过阻断免疫系统的特定信号为急性肝衰竭患者提供了新的治疗选择。
局限性
- 这些效应在离体和较晚时间点消失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Interleukin (IL)-1-type cytokines including IL-1α, IL-1β and interleukin-1 receptor antagonist (IL-1Ra) are among the most potent molecules of the innate immune system and exert biological activities through the ubiquitously expressed interleukin-1 receptor type 1 (IL-1R1). The role of IL-1R1 in hepatocytes during acute liver failure (ALF) remains undetermined. METHODS: The role of IL-1R1 during ALF was investigated using a novel transgenic mouse model exhibiting deletion of all signaling-capable IL-1R isoforms in hepatocytes (Il1r1Hep-/-). RESULTS: ALF induced by D-galactosamine (D-GalN) and lipopolysaccharide (LPS) was significantly attenuated in Il1r1Hep-/- mice leading to reduced mortality. Conditional deletion of Il1r1 decreased activation of injurious c-Jun N-terminal kinases (JNK)/c-Jun signaling, activated nuclear factor-kappa B (NF-κB) p65, inhibited extracellular signal-regulated kinase (ERK) and prevented caspase 3-mediated apoptosis. Moreover, Il1r1Hep-/- mice exhibited reduced local and systemic inflammatory cytokine and chemokine levels, especially TNF-α, IL-1α/β, IL-6, CC-chemokine ligand 2 (CCL2), C-X-C motif ligand 1 (CXCL-1) and CXCL-2, and a reduced neutrophil recruitment into the hepatic tissue in response to injury. NLRP3 inflammasome expression and caspase 1 activation were suppressed in the absence of the hepatocellular IL-1R1. Inhibition of IL-1R1 using IL-1ra (anakinra) attenuated the severity of liver injury, while IL-1α administration exaggerated it. These effects were lost ex vivo and at later time points, supporting a role of IL-1R1 in inflammatory signal amplification during acute liver injury. CONCLUSION: IL-1R1 in hepatocytes plays a pivotal role in an IL-1-driven auto-amplification of cell death and inflammation in the onset of ALF. LAY SUMMARY: Acute liver injury which can cause lethal liver failure is medicated by a class of proteins called cytokines. Among these, interleukin-1 (IL-1) and the corresponding receptor IL-1R1 play a prominent role in the immune system, but their role in the liver is undetermined. In the current study, a novel mouse model with defective IL-1R1 in liver cells was studied. Mice lacking this receptor in liver cells were protected from cell death to a certain extent. This protection occurred only in the presence of other, neighboring cells, arguing for the involvement of proteins derived from these cells. This effect is called paracrine signaling and the current study has for the first time shown that the IL-1R1 receptor on hepatocytes is involved in acute liver failure in this context. The approved drug anakinra - which blocks IL-1R1 - had the same effect, supporting the proposed mechanism of action. The findings of this study suggest new treatment options for patients with acute liver failure by blocking defined signals of the immune system.
引用
- Gehrke N, Hövelmeyer N, Waisman A, et al. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation. J Hepatol. 2018. PMID: 29366909. doi:10.1016/j.jhep.2018.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。